Salmonella enterica serovar Typhi (S. Typhi) is the causative agent of typhoid fever, a 27 systemic human infection with a burden exceeding 20 million cases each year that occur 28 disproportionately among children in low and middle income countries. Antimicrobial therapy 29 is the mainstay for treatment, but resistance to multiple agents is common. Here we report 30 genotypes and antimicrobial resistance (AMR) determinants detected from routine whole-31 genome sequencing (WGS) of 533 S. Typhi isolates referred to Public Health England 32 between April 2014 and April 2017, 488 (92%) of which had accompanying patient travel 33 information obtained via an enhanced surveillance questionnaire. The majority of cases 34 involved S. Typhi 4.3.1 (H58) linked with travel to South Asia (58%). Travel to East and West
Introduction 7 PRJNA248792. Individual accession numbers for isolates analysed in this study are given in 161 S1 Table. 162 163
Single nucleotide variant (SNV) analysis and in silico genotyping 164
Paired end Illumina reads were mapped to the CT18 reference genome (accession 165 AL513382) [30] , which is the standard reference for S. Typhi genomic studies, using RedDog 166 (V1.beta10.3) available at (https://github.com/katholt/RedDog). Briefly, RedDog maps reads 167 to the reference genome using Bowtie2 (v.2.2.9) [31] , before using SAMtools (v1.3.1)[32] to 168 identify high quality single nucleotide variant (SNV) calls as previously described [19] . A core 169 SNV alignment was generated for all SNV loci with consensus base calls (phred score >20) 170 in >95% of genomes; this alignment was filtered to exclude SNVs in phage regions and defined previously [10] ; S2 Table) and recombinant regions identified by Gubbins [33] . The 173 resulting alignment of 8053 SNVs was used as input to RAxML (v8.2.8) to infer a maximum 174 likelihood (ML) phylogeny with a generalised time-reversible model and a Gamma 175 distribution to model site-specific rate variation (GTR+ Γ substitution model; GTRGAMMA in and PlasmidFinder [36] . Genes were called as present within a genome when detected with 190 100% coverage and >90% nucleotide identity to the reference gene. Genefinder was also 191 used to detect point mutations in the QRDR of chromosomal genes gyrA (codons 83, 87) 192 and parC (codons 79, 80, 84) [37, 38] 
224
Trees annotated with MDR, IS1 insertion sites, plasmid replicons and QRDR point mutations 225 were visualised using ggtree v1.8.1 [45] . An interactive version of the S. Typhi ML phylogeny 226 with associated metadata is found at microreact (https://microreact.org/project/r1njJ_qJ4 ).
228

Ciprofloxacin susceptibility phenotyping 229
The minimum inhibitory concentration (MIC) of ciprofloxacin was measured for 173 isolates 230 (n = 117 in 2015 and n = 56 from 2016) as part of a previously reported study [37] . Briefly,
231
MIC was determined by agar dilution using Mueller-Hinton agar, and S. 
South East Asia
Indonesia 3 0 (0%) 0 (0%) 3 (100%) 0 (0%) 0 (0%)
Philippines 4 0 (0%) 0 (0%) 4 (100%) 0 (0%) 0 (0%)
Middle East
Iraq 3 1 (33.3%) 0 (0%) 2 (66.7%) 1 (33.3%) 0 (0%)
Other Regions
China 1 0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
S. Typhi genotypes by region 271
The 533 genomes were assigned to 31 unique S. Typhi genotypes using the GenoTyphi 272 scheme (Fig. 2) (Fig. 3) . Notably, 4.3.1 was not detected in 283 cases associated with travel to West Africa (0/11; see Table 1 , Fig. 3) . Other common 284 genotypes include clade 3.3 (6% of total isolates), found in cases with travel to India (9% of 285 all isolates from this location), or Bangladesh (15%); clade 2.2 (3.1% of total isolates), found 286 in cases with travel to India (2%) or Pakistan (4.5%); subclade 3.2.2 (2.6% of total isolates), 287 found in 21% of cases with travel to Bangladesh; and subclade 3.1.1 (1.7% of total isolates), 3). At the regional level, MDR was common amongst cases associated with travel to East differences between countries within these regions, associated with differences in the 324 dominant S. Typhi clades (Fig. 3) 
340
Africa (43%,) and West Africa (27%; see Table 1 ).
342
Ciprofloxacin MICs have been previously reported for 173 of the S. Typhi isolates (S1 343   Table) [37], and a comparison of QRDR mutations with these phenotypes is shown in Fig. 4 344 to facilitate the interpretation of QRDR mutations. These data showed that all isolates 345 carrying a single QRDR mutation had ciprofloxacin MIC of at least 0.064 µg/mL (exceeding 346 the EUCAST threshold for susceptibility); all those with two QRDR mutations had MIC of 1 5 resistance) (Fig. 4) . The most common mutations were gyrA-S83F (n=271, 51%) and gyrA-349 S83Y (n=83, 16%), which were found in 18 genotypes in cases associated with travel to 350 eleven and six countries respectively ( Table 2) . Double mutants (gyrA-S38F or -S83Y plus a 351 mutation in parC), associated with elevation of ciprofloxacin MIC to ≥ 0.25 µg/mL (Fig. 4) ,
352
were found in 16 isolates (3.0%) associated with travel to India or Bangladesh. A total of 61 353 isolates were identified as QRDR triple mutants, which display resistance to ciprofloxacin 354 (MIC >1 µg/mL, see Fig. 4 ) and have been associated with fluoroquinolone treatment while the remaining two had a unique profile of gyrA-S83F, gyrA-D87G and parC-S80I and 357 of gyrA-S83FY, parC-Y74X and parC-P98X ( Table 2) . 
359
390
Plasmid vs chromosomal location of AMR genes in S. Typhi 391
All MDR isolates belonged to 4.3.1 (n=125) or 3.1.1 (n=4) and carried the typical S. Typhi
392
MDR composite transposon comprising Tn6029 (encoding bla TEM-1 , sul2, strAB) inserted in 393 Tn21 (carrying a class I integron encoding dfrA alleles in the gene cassette and sul1 at the 394 end), which is in turn inserted within Tn9 (encoding catA1) [47] (see Fig. 5a ). All 125 MDR 395 4.3.1 isolates (associated with South Asia and East Africa) carried dfrA7 in the integron 396 cassette and no plasmid replicons (Fig. 5a) . In most of these (n=123, 98%), we detected 397 chromosomal IS1 insertions at sites previously associated with IS1-mediated integration of 398 the MDR composite transposon (S1 Fig.) (cyaA or yidA sites [12, 18] ). A putative IS1 399 insertion was detected in the novel site STY3168 in a single genome (SRR5500440).
400
Further, of the six isolates with four IS1 sites detected, five had recent travel to Pakistan with 401 last isolate having no reported travel (S1 Fig.) . Notably, most (93%) of the MDR 4.3.1 402 isolates also carried a QRDR mutation, the most common being gyrA-S83F ( Table 2, 404 plasmids with dfrA15 in the integron cassette ( Fig. 5b) . An IncHI1 PST2 plasmid was also 405 identified in a single non-MDR 2.3.1 isolate associated with travel to Nigeria. The plasmid 406 backbone was very closely related to that of the 3.1.1 West African plasmids but carried 407 dfrA1 in the integron cassette and lacked the chloramphenicol and ampicillin resistance 408 genes catA1 and bla TEM (Fig. 5a-b) . 
412
is shown (accession ERL12960). MDR genes are those encoding resistance to the first line 1 likely that MDR will be maintained even in the absence of selection for the specific 498 resistances encoded. We showed that the two most common sites for chromosomal 499 integration of the MDR element was at the known sites yidA or upstream of cyaA in the 500 4.3.1.1 lineage. Of particular note was the increase in number of IS1 insertions in from cases 501 in subclade 4.3.1.1 with reported travel to Pakistan (S1 Fig.) . We may hypothesise that the 502 S. Typhi from this region may be more likely to acquire novel mechanisms in response to 503 local selective pressures. Indeed, the recent acquisition of an IncY plasmid harbouring 504 bla and qnrS genes has resulted in the emergence of an XDR lineage of S. Typhi from 505 Pakistan [24] and an IncI1 plasmid encoding bla in an S. Typhi from Bangladesh [51] 506 provides evidence for this hypothesis, highlighting the importance of ongoing surveillance of 507 these regions that experience a high burden of typhoid fever.
509
Currently there are three critical AMR threats posed by S. Typhi, namely the dissemination 510 of mobile AMR genes mediating MDR profiles, the evolution of point mutations in gyrA and 511 parC, two core housekeeping genes, that confer differing levels of fluoroquinolone 512 resistance (Fig. 2, Fig. 4) , and the recent emergence of XDR S. Typhi. The WGS data 513 presented here provide insight into changing AMR dynamics within S. Typhi. Importantly, the 514 concordance of genomic and phenotypic AMR data for ciprofloxacin resistance in this study 515 ( Fig. 4) 
